Hantavirus Outbreak, Germany, 2007

1. Centers for Disease Control, Taiwan. Statistics of Communicable Diseases and Surveillance Report, Republic of China, 2004 and 2005 [cited 2008 Mar 18]. Available from http://www.cdc.gov.tw/public/ Data/8324174197.pdf 2. Jou R, Chuang PC, Wu YS, Yan JJ, Luh KT. Drug-resistant Mycobacterium tuberculosis, Taiwan. Emerg Infect Dis. 2006;12:871–2. 3. World Health Organization. Anti-tuberculosis drug resistance in the world report no. 3. Geneva: The Organization. 2004 [cited 2008 Mar 18]. Available from http:// www.who.int/tb/publications/who_htm_ tb_2004_343/en/index.html 4. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs—worldwide, 2000–2004. MMWR. 2006;55:301–5. 5. World Health Organization. Extensively drug-resistant tuberculosis (XDRTB): recommendations for prevention and control. Wkly Epidemiol Rec. 2006; 81:430–2. 6. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603–62. 7. Ginsburg AS, Hooper N, Parrish N, Dooley KE, Dorman SE, Booth J, et al. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis. 2003;37:1448–52. 8. Yu MC, Suo J, Lin TP, Luh KT. In vitro activity of ofl oxacin against Mycobacterium tuberculosis. J Formos Med Assoc. 1997;96:13–6. 9. Huang TS, Kunin CM, Lee SS, Chen YS, Tu HZ, Liu YC. Trends in fl uoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical center: 1995–2003. J Antimicrob Chemother. 2005;56:1058–62. 10. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575–80.